InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.075
-0.005 (-0.24%)
At close: Apr 2, 2025, 4:00 PM
2.205
+0.130 (6.28%)
After-hours: Apr 2, 2025, 7:47 PM EDT

InMed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Market Capitalization
323102632
Upgrade
Market Cap Growth
57.02%-23.21%-68.01%-62.35%-20.62%-27.47%
Upgrade
Enterprise Value
-0-4-651626
Upgrade
Last Close Price
2.085.3118.53235.201590.003088.80
Upgrade
PS Ratio
0.240.520.758.85--
Upgrade
PB Ratio
0.240.260.261.063.475.49
Upgrade
P/TBV Ratio
0.770.320.301.384.056.73
Upgrade
EV/Sales Ratio
--4.24--
Upgrade
Debt / Equity Ratio
0.150.110.030.090.040.05
Upgrade
Asset Turnover
0.410.360.310.10--
Upgrade
Inventory Turnover
3.382.441.33---
Upgrade
Quick Ratio
2.083.534.611.903.353.52
Upgrade
Current Ratio
3.054.415.662.893.783.77
Upgrade
Return on Equity (ROE)
-83.50%-72.08%-75.09%-226.07%-153.95%-92.74%
Upgrade
Return on Assets (ROA)
-40.86%-39.22%-38.94%-75.28%-70.65%-51.18%
Upgrade
Return on Capital (ROIC)
-46.07%-44.89%-46.85%-96.98%-89.75%-58.38%
Upgrade
Earnings Yield
-315.92%-324.14%-257.74%-192.96%-39.86%-27.72%
Upgrade
FCF Yield
-291.13%-295.41%-241.44%-162.08%-38.25%-23.00%
Upgrade
Buyback Yield / Dilution
-154.47%-211.26%-336.59%-108.64%-28.72%-0.83%
Upgrade
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q